🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Joelle leads @RadiotherapyOn1 #ProstateCa study of QOL⬇️at 1 year: HDR boost (grey) vs HDR mono (orange) vs SABR (blue). 7 prospective Sunnybrook Health Sciences Centre studies, n=648. Sexual: SABR > HDRm > HDRb Bladder: (HDRm = SABR) > HDRb Bowel: HDRm > (SABR = HDRb) authors.elsevier.com/a/1f197cA0-AtQC

In this recent #ICESWestern study, Jacques Raphael et al found the use of #immunotherapy to treat advanced #cancers rose substantially in Ontario since its approval. bit.ly/3sDhNRP 1/

Are you an inspirational leader in #Oncology? Come join the Department of Oncology Schulich WesternU London Health Sciences Centre in London, Ontario as our new Chair/Chief! We are a fantastic multidisciplinary and collaborative academic clinical department. Please RT uwo.ca/facultyrelatio…

Immune-Related Toxic Effects and Treatment Outcomes in Patients With Cancer and Autoimmune Diseases Receiving Immune Checkpoint Inhibitor Therapy ascopost.com/news/july-2022… #oncology #cancer #immunotherapy

Another Abdulla Rashdan, MD, JB, FRCPC study with @lbarbera123 exploring effect of Radiotherapy with Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study redjournal.org/article/S0360-… #bscm #radonc

Analysis of overall survival data from the IMpower010 trial shows overall survival trend in favor of atezolizumab in the PD-L1 TC > 1% stage II-IIIA population but not in the all randomized stage II-IIIA or intent-to-treat population per research presented today at #WCLC22. #LCSM

In the initial NADIM trial, neoadjuvant chemoimmunotherapy was shown to be highly effective in patients with resectable stage IIIA #NSCLC. Today at #WCLC22, the researchers from the NADIM trial presented new data that supports the conclusions of the initial NADIM trial. #LCSM

🎯Interesting study on pre-existing autoimmune disease in pts treated with anti-PD-1👏 JNCI doi.org/10.1093/jnci/d… ✅17 497 pts, retrosp. ✅Risk of mortality not ⬆️ ✅some cases w favorable prognosis 👉underlying AD may not be a contraindication for IO ESMO - Eur. Oncology OncoAlert

Review of pathologic complete response (pCR) shows that evidence currently available does not support pCR used alone as a reliable surrogate endpoint in neoadjuvant randomized controlled trials for breast cancer. ja.ma/3En94dh #BCSM

Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer | Journal of Clinical Oncology ascopubs.org/doi/abs/10.120…

Important study. 1/5 pts over age 65 receiving std adj chemo received low relative dose intensity and had INFERIOR outcome. Reducing dose is not the first solution, choice of regimen, growth factors and supportive care are critical. OncoAlert

The European Organisation for Research and Treatment of Cancer (EORTC) endorses #TargetTrial emulation with #RWD. An organization with unmatched expertise in the design of #randomizedtrials embraces their explicit emulation when using observational data. ejcancer.com/article/S0959-…

ICES welcomes Jacques Raphael as a new scientist! Jacques' work includes conducting health services research, systematic reviews, and meta-analyses. Learn more about his research bit.ly/40FsAZY

#CAMO23 Congratulations👏 to Dr. Nupur Krishnan for Best Poster Presentation➡️Immune checkpoint inhibitors in the treatment of small cell lung cancer: A systematic review and meta-analysis Sharlene Gill, MD, MPH, MBA, FASCO CAMOPREZ Dr Zachary Veitch

“A cancer patient. A cancer case. Common terms, but ones that can have a great impact on patients and their mental health.” A new The Lancet Oncology Editorial discusses person-first language and treating patients with respect at every turn: hubs.li/Q024gWnc0

A study by Jacques Raphael et al. shows early mortality is common among patients with cancer treated with immunotherapy. The study suggests the need for a predictive tool to improve patient selection for ICI treatment in routine clinical practice. Read here: doi.org/10.1093/jnci/d…

THE EDMONTON OILERS HAVE FORCED A #GAME7!!!! 🤩 #StanleyCup

“War cannot be humanized, only abolished” (A. Einstein)

Hady Habib does it! Two days ago Lebanon had never had a Grand Slam main draw participant, now they have a match winner! And look at what it means! He defeats Bu 7-6(4) 6-4 7-6(6) Wide World of Sports • ESPN • @eurosport • WOWOWテニス • #AusOpen • #AO2025

Well done, Canada